SCHEMBL1775606

SCHEMBL1775606

O=C(CF)C(F)F.O=C1c2ccc1s2

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115376 0.76 HPGD (0.34) HPGD
SCHEMBL620772 0.75
Water SCHEMBL542921 0.72
SCHEMBL28987617 0.72
Acetone SCHEMBL28144848 0.63 CES2 (0.37)
SCHEMBL16370920 0.61 CES2 (0.35)
SCHEMBL23581763 0.60 DAO (0.50) HPGD
SCHEMBL8635819 0.59 GSK3B (0.58) HPGD
SCHEMBL1953538 0.57 KMT2A (0.64) HPGD
SCHEMBL2171289 0.57 CES2 (0.34) HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7943600-B2 Antimicrobial combination therapy MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2011-05-17 US disclosed
US-20060193924-A1 Antimicrobial combination therapy NATIONAL INSTITUTES OF HEALTH 2006-08-31 US disclosed
WO-2006071685-A2 ANTIMICROBIAL COMBINATION THERAPY COMPRISING AN ANTIBIOTIC AND TOXIC COMPOUND SELECTED FROM DNA DAMAGING AGENTS, ALKYLATING AGENTS, HEAVY METAL CONTAINING COMPOUNDS AND CHELATING AGENTS MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2006-07-06 WO disclosed